Literature DB >> 1130750

The competing risks of tuberculosis and hepatitis for adult tuberculin reactors.

G W Comstock, P Q Edwards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1130750     DOI: 10.1164/arrd.1975.111.5.573

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  7 in total

Review 1.  Dormancy of Mycobacterium tuberculosis and latency of disease.

Authors:  L G Wayne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

2.  Chemoprophylaxis of respiratory infections.

Authors:  J Batten
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

3.  Chemoprophylaxis against tuberculosis.

Authors:  D L Coleman; G Slutkin
Journal:  West J Med       Date:  1984-01

Review 4.  Anti-tuberculosis treatment strategies and drug development: challenges and priorities.

Authors:  Véronique A Dartois; Eric J Rubin
Journal:  Nat Rev Microbiol       Date:  2022-04-27       Impact factor: 78.297

5.  Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial.

Authors:  S Grzybowski; M J Ashley; G Pinkus
Journal:  Can Med Assoc J       Date:  1976-04-03       Impact factor: 8.262

6.  Evaluation of isoniazid-associated hepatitis by immunological tests.

Authors:  R J Warrington; K S Tse; B A Gorski; R Schwenk; A H Sehon
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

7.  The convergent epidemiology of tuberculosis and human cytomegalovirus infection.

Authors:  Frank Cobelens; Nico Nagelkerke; Helen Fletcher
Journal:  F1000Res       Date:  2018-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.